
Helix Nanotechnologies YC 지원서
Helix Nanotechnologies은(는) Winter 2017 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.
- YC 배치
- Winter 2017
- 산업
- HealthcareDrug Discovery and Delivery
- 팀 규모
- 22
- 상태
- Active
- 출시됨
- 2016
창업자
Nikolai EroshenkoFounder/CSO
Helix Nanotechnologies의 사업 내용
Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button. By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity. Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas. We've started rolling out some of our new tech - moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.
Helix Nanotechnologies의 YC 지원서, 재구성됨
Y Combinator 지원
Helix Nanotechnologies, Winter 2017 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Helix Nanotechnologies
Next-generation mRNA platform for disease and climate
We are building an mRNA platform that improves the speed and cost of developing therapies. Our technology allows experiments that once took months or years to be done in weeks, and for thousands of dollars instead of millions. We are advancing a COVID-19 vaccine candidate for the immunocompromised and testing an intervention aimed at climate impact.
We live and work in Boston and Cambridge, MA, and will base the company there after YC.
Boston and Cambridge are biotech hubs with deep scientific talent and collaborators. Being here helps us attract the right team and stay on the cutting edge of RNA technology.
전체 지원서에서 21개의 추가 답변
Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.
자주 묻는 질문
Helix Nanotechnologies의 실제 YC 지원서인가요?
아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 Helix Nanotechnologies의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. Helix Nanotechnologies과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.
Helix Nanotechnologies은(는) 어떤 YC 배치에 있었나요?
Helix Nanotechnologies은(는) Y Combinator Winter 2017 배치에 참여했습니다.
Helix Nanotechnologies은(는) 누가 설립했나요?
Helix Nanotechnologies은(는) Nikolai Eroshenko(이)가 설립했습니다.
Helix Nanotechnologies은(는) 무엇을 하나요?
Next-generation mRNA platform to solve cancer, COVID and climate.
전체 재구성된 지원서를 어떻게 읽나요?
무료 Round Funded 계정을 만드세요. Helix Nanotechnologies의 전체 26개 질문 버전 지원서와 모든 YC 배치 지원서는 YC Insights에서 확인할 수 있습니다.